Form Filed By Lamy Patrick
Fri, Jun 20, 2025
Go to original document
Akero Therapeutics, Inc. (AKRO)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2025-06-20
Common Stock
Sale
S
Type
Disposed 875 shares @ $54.59 per share
31,698 shares
Direct
Footnotes
1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. Such sales were automatic and not at the discretion of the Reporting Person.